Active-Duty Soldiers to Receive MDMA Therapy for PTSD Under New Military Doctrine

The U.S. military is set to implement a new doctrine allowing active-duty soldiers to receive MDMA-assisted therapy to help process trauma and potentially extend their service. This initiative represents a significant shift in how the armed forces approach mental health treatment and retention strategies. Critics may view this as expanding the use of controlled substances within the military, while proponents argue it addresses critical PTSD needs.